Identification of a tumour suppressor network opposing nuclear Akt function (original) (raw)

• Luo, J., Manning, B. D. & Cantley, L. C. Targeting the PI3K–Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257–262 (2003)
  Article CAS PubMed Google Scholar
• Brenkman, A. B. & Burgering, B. M. FoxO3a eggs on fertility and aging. Trends Mol. Med. 9, 464–467 (2003)
  Article CAS PubMed Google Scholar
• Salomoni, P. & Pandolfi, P. P. The role of PML in tumor suppression. Cell 108, 165–170 (2002)
  Article CAS PubMed Google Scholar
• Gurrieri, C. et al. Loss of the tumour suppressor PML in human cancers of multiple histologic origins. J. Natl Cancer Inst. 96, 269–279 (2004)
  Article CAS PubMed Google Scholar
• Goel, A. et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res. 64, 3014–3021 (2004)
  Article CAS PubMed Google Scholar
• Porkka, K. P. & Visakorpi, T. Molecular mechanisms of prostate cancer. Eur. Urol. 45, 683–691 (2004)
  Article CAS PubMed Google Scholar
• Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nature Genet. 19, 348–355 (1998)
  Article CAS PubMed Google Scholar
• Podsypanina, K. et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. USA 96, 1563–1568 (1999)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Suzuki, A. et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169–1178 (1998)
  Article CAS PubMed Google Scholar
• Di Cristofano, A. et al. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285, 2122–2125 (1999)
  Article CAS PubMed Google Scholar
• Trotman, L. C. et al. Pten dose dictates cancer progression in the prostate. PLoS Biol. 1, E59 (2003)
  Article PubMed PubMed Central Google Scholar
• Wang, S. et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4, 209–221 (2003)
  Article CAS PubMed Google Scholar
• Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. & Pandolfi, P. P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature Genet. 27, 222–224 (2001)
  Article CAS PubMed Google Scholar
• Maehama, T., Taylor, G. S. & Dixon, J. E. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu. Rev. Biochem. 70, 247–279 (2001)
  Article CAS PubMed Google Scholar
• Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29–39 (1998)
  Article CAS PubMed Google Scholar
• Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor–mTOR complex. Science 307, 1098–1101 (2005)
  Article ADS CAS PubMed Google Scholar
• Brazil, D. P., Yang, Z. Z. & Hemmings, B. A. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233–242 (2004)
  Article CAS PubMed Google Scholar
• Tran, H., Brunet, A., Griffith, E. C. & Greenberg, M. E. The many forks in FOXO's road. Sci. STKE 2003, RE5 (2003)
  PubMed Google Scholar
• Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868 (1999)
  Article CAS PubMed Google Scholar
• Castrillon, D. H., Miao, L., Kollipara, R., Horner, J. W. & DePinho, R. A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301, 215–218 (2003)
  Article ADS CAS PubMed Google Scholar
• Hosaka, T. et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl Acad. Sci. USA 101, 2975–2980 (2004)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Millward, T. A., Zolnierowicz, S. & Hemmings, B. A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24, 186–191 (1999)
  Article CAS PubMed Google Scholar
• Gao, T., Furnari, F. & Newton, A. C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13–24 (2005)
  Article CAS PubMed Google Scholar
• Janssens, V., Goris, J. & Van Hoof, C. PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15, 34–41 (2005)
  Article CAS PubMed Google Scholar
• Li, L., Ren, C. H., Tahir, S. A., Ren, C. & Thompson, T. C. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol. Cell. Biol. 23, 9389–9404 (2003)
  Article CAS PubMed PubMed Central Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000)
  Article CAS PubMed Google Scholar
• Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of _Pten_-deficient tumorigenesis. Nature 436, 725–730 (2005)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Wang, Z. G. et al. PML is essential for multiple apoptotic pathways. Nature Genet. 20, 266–272 (1998)
  Article CAS PubMed Google Scholar
• Guo, A. et al. The function of PML in p53-dependent apoptosis. Nature Cell Biol. 2, 730–736 (2000)
  Article CAS PubMed Google Scholar
• Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011–2015 (2004)
  Article ADS CAS PubMed Google Scholar